PRESS RELEASE published on 05/19/2023 at 22:15, 3 years 3 months ago Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 05/16/2023 at 14:30, 3 years 4 months ago Jaguar Health to Present at Lytham Partners Spring 2023 Investor Conference & Participate in Animal Health Panel
PRESS RELEASE published on 05/15/2023 at 14:30, 3 years 4 months ago Jaguar Health Reports First Quarter 2023 Financial Results
PRESS RELEASE published on 05/11/2023 at 14:30, 3 years 4 months ago Canalevia-CA1, Jaguar Animal Health’s FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs, Now Available from Chewy
PRESS RELEASE published on 05/10/2023 at 14:30, 3 years 4 months ago Jaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company's FDA-approved Prescription Drug
PRESS RELEASE published on 05/09/2023 at 14:30, 3 years 4 months ago Jaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 05/08/2023 at 14:30, 3 years 4 months ago Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates
PRESS RELEASE published on 05/05/2023 at 22:15, 3 years 4 months ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 05/01/2023 at 14:30, 3 years 4 months ago Napo Therapeutics Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress in Abu Dhabi
PRESS RELEASE published on 04/27/2023 at 14:30, 3 years 4 months ago U.S. Veterinary Oncologists Participating in a New Survey Prefer Canalevia-CA1 Over the Current Standard of Care
Published on 09/16/2026 at 16:55, 2 hours 23 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 4 hours 18 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 5 hours 18 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 13:30, 5 hours 48 minutes ago Sterling Extends Core MEPS Copper Zone to 700m; Intersects 200m of 0.53% CuEq Including 102m of 0.81% CuEq
Published on 09/16/2026 at 13:23, 5 hours 55 minutes ago SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 19:05, 13 minutes ago EcoFlow to showcase its open home energy ecosystem at Solar & Storage Live Zurich 2026
Published on 09/16/2026 at 18:22, 56 minutes ago EQS-Adhoc: elumeo SE resolves on a capital increase against cash contributions, ex-cluding pre-emptive rights, and a move to the Scale segment
Published on 09/16/2026 at 18:11, 1 hour 7 minutes ago EQS-Adhoc: Berentzen-Gruppe Aktiengesellschaft confirms rumours regarding negotiations on a voluntary takeover offer by SAZERAC COMPANY, INC.
Published on 09/16/2026 at 18:05, 1 hour 13 minutes ago LawZero receives a commitment of up to $300M in joint funding from Canada and Germany
Published on 09/16/2026 at 17:45, 1 hour 33 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 12 hours 18 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 1 hour ago Report on the Combined General Meeting of the 10th of September 2026
